Global Vaccines Market : Industry Size, Growth, Analysis and Forecast to 2025
- DPI3198893
- 220 Pages
- June 2019
- Pharmaceuticals
“Global Vaccines Market: Industry Size, Growth, Analysis and Forecast to 2025” presents an in–depth assessment of the global vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up–to–date industry data on the actual market situation and future outlook for the global vaccines market. The report includes historical data from 2015 to 2018 and forecasts until 2025.
The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025. The report provides clear insight into current and future developments of the global vaccines market. The report explores a detailed analysis of the top 42 vaccines market value assessment globally from 2015 to 2018 and forecasts to 2025.
Additionally, the report includes an assessment of promising vaccines in clinical development by major companies. Key trends in terms of collaboration, merger & acquisitions, partnerships, distribution, exclusive and licensing agreement are analyzed with details. The report also explores the detailed description of growth drivers and inhibitors of the global vaccines market.
The report concludes with the profiles of major players in the global vaccines market. The key market players are evaluated on various parameters such as business overview, vaccines portfolios, promising vaccines in the clinical development, vaccines market value analysis and recent development.
Long–term Growth Projection:
• Merck acquired Immune Design in 2019
• Shingrix is set to achieve blockbuster vaccine status in 2019
• Prevnar / Prevnar 13 has captured the highest market share of the global vaccines market
• With a market value of more than US$ 7 billion, GSK led the global vaccines market in 2018
Top 42 Vaccines Covered Under This Report Are:
1. Prevnar / Prevnar 13
2. Gardasil / Gardasil 9
3. Vaxigrip
4. Fluzone
5. Flublok
6. Varivax
7. Menactra
8. Proquad
9. Pneumovax 23
10. Fluarix/FluLaval
11. Havrix/Twinrix/Engerix–B
12. Priorix, Priorix Tetra, Varilrix
13. M–M–R II
14. Adacel
15. Boostrix
16. Bexsero
17. Menveo
18. Cervarix
19. Trumenba
20. Shingrix
21. Pentacel, Pentaxim, Imovax, Hexaxim
22. Rotateq
23. Zostavax
24. Rotarix
25. Synflorix
26. Pediarix,Infanrix
27. Ticovac
28. Biken Ha
29. Tetrabik
30. Mearubik
31. Varicella (MTP)
32. Jebik V
33. Flumist/Fluenz
34. Bio Thrax
35. Dukoral
36. Ixiaro
37. In Live
38. HeaLive
39. BiLive
40. Anflu
41. EasySix
42. Imvamune
The major companies dominating this market for its products, services, and continuous product developments are:
1. Sanofi Pasteur
2. GlaxoSmithKline (GSK)
3. Merck
4. Pfizer
5. AstraZeneca
6. Mitsubishi Tanabe Pharma
7. Emergent Biosolutions
8. Astellas Pharma Inc
9. Valneva
10. Seqirus
11. Bavarian Nordic
12. Sinovac
13. Panacea Biotec
14. Bharat Biotech
15. Serum Institute of India
16. Biological E. Limited
The Latest Industry Data Included in this Report:
• Global Vaccines Market Size & Analysis (2015 – 2025)
• Market Share Analysis of Global Vaccines Market (%),2015 – 2025
• Global Vaccines Market Share, By Brand
• Global Vaccines Market Share, By Company
• Global Top 42 Vaccines Market Assessment & Opportunity (Value),2015 – 2025
• Major Companies Vaccines Market Value Analysis & Forecast
• Promising Vaccines in Clinical Development by Major Companies
• Detailed Vaccines Portfolio of the Major Companies
• Major Deals in the Global Vaccines Market
• Key Market Drivers and Inhibitors of the Global Vaccines Market
• Major Companies Analysis
The Report Answers the Following Questions about the Global Vaccines Market:
• What is the size of the global vaccines market during 2015–2025?
• What will be the revenue generated by each vaccine during the forecast period?
• Which vaccine provides the highest market share?
• What are the leading companies dominating the global vaccines market? What is the share of these companies in the global vaccines market?
• How will the industry evolve during the forecast period 2019 – 2025?
• What are the key drivers and inhibitors in the current market?
• What is the key development implemented by the leading players to stand out in this market?
• Who are the key players in this market space?
2. Global Vaccines Market Size & Analysis (2015 – 2025)
3. Market Share Analysis of Global Vaccines Market (%),2015 – 2025
3.1 Global Vaccines Market Share, By Brand
3.2 Global Vaccines Market Share, By Company
4. Key Drivers and Inhibitors of the Global Vaccines Market
4.1 Market Drivers
4.2 Market Inhibitors
5. Global Top 42 Vaccines Market Assessment & Opportunity (Value),2015 – 2025
5.1 Prevnar / Prevnar 13
5.2 Gardasil / Gardasil 9
5.3 Vaxigrip
5.4 Fluzone
5.5 Flublok
5.6 Varivax
5.7 Menactra
5.8 Proquad
5.9 Pneumovax 23
5.10 Fluarix/FluLaval
5.11 Havrix/Twinrix/Engerix–B
5.12 Priorix, Priorix Tetra, Varilrix
5.13 M–M–R II
5.14 Adacel
5.15 Boostrix
5.16 Bexsero
5.17 Menveo
5.18 Cervarix
5.19 Trumenba
5.20 Shingrix
5.21 Pentacel, Pentaxim, Imovax, Hexaxim
5.22 Rotateq
5.23 Zostavax
5.24 Rotarix
5.25 Synflorix
5.26 Pediarix,Infanrix
5.27 Ticovac
5.28 Biken Ha
5.29 Tetrabik
5.30 Mearubik
5.31 Varicella (MTP)
5.32 Jebik V
5.33 Flumist/Fluenz
5.34 Bio Thrax
5.35 Dukoral
5.36 Ixiaro
5.37 In Live
5.38 HeaLive
5.39 BiLive
5.40 Anflu
5.41 EasySix
5.42 Imvamune
5.43 Other Vaccines
6. Major Deals in Global Vaccines Market
6.1 Merger & Acquisitions
6.2 Collaboration Deal
6.3 Licensing Agreement
6.4 Exclusive Agreement
6.5 Distribution Agreement
6.6 Partnerships
7. Key Companies Analysis
7.1 Sanofi Pasteur
7.1.1 Business Overview
7.1.2 Vaccines Portfolio
7.1.3 Vaccines Market Value Analysis & Forecast
7.1.4 Promising Vaccines in Clinical Development
7.1.5 Recent Development
7.2 GlaxoSmithKline (GSK)
7.2.1 Business Overview
7.2.2 Vaccines Portfolio
7.2.3 Vaccines Market Value Analysis & Forecast
7.2.4 Promising Vaccines in Clinical Development
7.2.5 Recent Development
7.3 Merck
7.3.1 Business Overview
7.3.2 Vaccines Portfolio
7.3.3 Vaccines Market Value Analysis & Forecast
7.3.4 Promising Vaccines in Clinical Development
7.3.5 Recent Development
7.4 Pfizer
7.4.1 Business Overview
7.4.2 Vaccines Portfolio
7.4.3 Vaccines Market Value Analysis & Forecast
7.4.4 Promising Vaccines in Clinical Development
7.4.5 Recent Development
7.5 AstraZeneca
7.5.1 Business Overview
7.5.2 Vaccines Portfolio
7.5.3 Vaccines Market Value Analysis & Forecast
7.5.4 Recent Development
7.6 Mitsubishi Tanabe Pharma
7.6.1 Business Overview
7.6.2 Vaccines Portfolio
7.6.3 Vaccine Market Value Analysis & Forecast
7.6.4 Promising Vaccines in Clinical Development
7.6.5 Recent Development
7.7 Emergent Biosolutions
7.7.1 Business Overview
7.7.2 Vaccines Portfolio
7.7.3 Vaccine Market Value Analysis & Forecast
7.7.4 Promising Vaccines in Clinical Development
7.7.5 Recent Development
7.8 Astlellas Pharma Inc
7.8.1 Business Overview
7.8.2 Vaccines Portfolio
7.8.3 Vaccines Market Value Analysis & Forecast
7.8.4 Recent Development
7.9 Valneva
7.9.1 Business Overview
7.9.2 Vaccines Portfolio
7.9.3 Vaccines Market Value Analysis & Forecast
7.9.4 Promising Vaccines in Clinical Development
7.9.5 Recent Development
7.10 Seqirus
7.10.1 Business Overview
7.10.2 Vaccines Portfolio
7.10.3 Vaccine Market Value Analysis & Forecast
7.10.4 Promising Vaccines in Clinical Development
7.10.5 Recent Development
7.11 Bavarian Nordic
7.11.1 Business Overview
7.11.2 Vaccines Portfolio
7.11.3 Vaccine Market Value Analysis & Forecast
7.11.4 Promising Vaccines in Clinical Development
7.11.5 Recent Development
7.12 Sinovac
7.12.1 Business Overview
7.12.2 Vaccines Portfolio
7.12.3 Vaccine Market Value Analysis & Forecast
7.12.4 Promising Vaccines in Clinical Development
7.12.5 Recent Development
7.13 Panacea Biotec
7.13.1 Business Overview
7.13.2 Vaccines Portfolio
7.13.3 Vaccine Market Value Analysis & Forecast
7.13.4 Promising Vaccines in Clinical Development
7.13.5 Recent Development
7.14 Bharat Biotech
7.14.1 Business Overview
7.14.2 Vaccines Portfolio
7.14.3 Promising Vaccines in Clinical Development
7.14.4 Recent Development
7.15 Serum Institute of India
7.15.1 Business Overview
7.15.2 Vaccines Portfolio
7.15.3 Promising Vaccines in Clinical Development
7.15.4 Recent Development
7.16 Biological E. Limited
7.16.1 Business Overview
7.16.2 Vaccines Portfolio
7.16.3 Promising Vaccines in Clinical Development
7.16.4 Recent Development
Table 3–2: Global Vaccines Market Share & Y–o–Y Growth By Brand Forecast (Percent), 2019 – 2025
Table 3–3: Global Vaccines Market Share & Y–o–Y Growth By Company Forecast (Percent), 2015 – 2018
Table 3–4: Global Vaccines Market Share & Y–o–Y Growth By Company Forecast (Percent), 2019 – 2025
Table 6–1: Merger & Acquisitions in the Global Vaccines Market
Table 6–2: Collaboration Deal in the Global Vaccines Market
Table 6–3: Licensing Agreement in the Global Vaccines Market
Table 6–4: Exclusive Agreement in the Global Vaccines Market
Table 6–5: Distribution Agreement in the Global Vaccines Market
Table 6–6: Partnerships in the Global Vaccines Market
Table 7–1: Sanofi Promising Vaccines in Clinical Development
Table 7–2: GSK Promising Vaccines in Clinical Development
Table 7–3: Merck Promising Vaccines in Clinical Development
Table 7–4: Pfizer Promising Vaccines in Clinical Development
Table 7–5: Mitsubishi Tanabe Pharma Promising Vaccines in Clinical Development
Table 7–6: Emergent Biosolutions Promising Vaccines in Clinical Development
Table 7–7: Valneva Promising Vaccines in Clinical Development
Table 7–8: Seqirus Promising Vaccines in Clinical Development
Table 7–9: Bavarian Nordic Promising Vaccines in Clinical Development
Table 7–10: Sinovac Promising Vaccines in Clinical Development
Table 7–11: Panacea Biotec Promising Vaccines in Clinical Development
Table 7–12: Bharat Biotech Promising Vaccines in Clinical Development
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
